•
Dec 31, 2013

AcelRx Q4 2013 Earnings Report

Total Revenue
$27.6M
Previous year: $1.7M
+1523.5%
EPS
-$3.6
Previous year: -$8.2
-56.1%
Gross Profit
$27.6M
Previous year: $1.68M
+1548.2%
Cash and Equivalents
$88.4M
Previous year: $47.9M
+84.4%
Free Cash Flow
$131M
Previous year: -$5.9M
-2325.4%
Total Assets
$110M
Previous year: $64.5M
+70.5%

AcelRx

AcelRx